Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Second Indication Application of Novo Nordisk Liraglutide to be Approved in China soon

CPhI.CNMay 13, 2020

Tag: Editor's Picks , Novo Nordisk , Liraglutide , type 2 diabetes

PharmaSources Customer Service